Drug intelligence / Profile preview

Simiao Xiaobi Decoction

Development stage
Unknown
Lead developer
Xiyuan Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Simiao Xiaobi Decoction (SXD) is a traditional Chinese medicine (TCM) herbal formula developed by Xiyuan Hospital of China Academy of Chinese Medical Sciences for the treatment of rheumatoid arthritis (RA). It is derived from the classical formula "Simiao Yongan Tang" and is specifically indicated for RA patients presenting with symptoms characterized in TCM theory as damp-heat and toxin accumulation. The decoction is composed of several herbal ingredients, including *Lonicera japonica* (Jinyinhua/honeysuckle), *Radix Angelicae Sinensis* (Danggui/Chinese angelica), *Hedyotis diffusa* (Baihuasheshecao), and *Radix Paeoniae Alba* (Baishao/white peony root). SXD is reported to possess anti-inflammatory and chondroprotective (cartilage-protecting) properties, which help reduce joint pain, swelling, and morning stiffness. It is administered orally and has been evaluated both as a monotherapy and in combination with conventional disease-modifying antirheumatic drugs (DMARDs). A granulated version, known as Simiao Xiaobi Granules, has also been developed for clinical use.

Brand names
Simiao Xiaobi Granules
Other names
Simiao Xiaobi Fang
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Simiao Xiaobi Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Simiao Xiaobi Decoction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call